This is a multicenter, double-blind, randomized, parallel-group, vehicle-controlled study to assess the safety and efficacy of dapsone 7.5% gel versus vehicle administered topically once daily for 12 weeks in patients with acne vulgaris.
This study will assess the safety and efficacy of dapsone gel versus vehicle control in patients with acne vulgaris.